Morgan Stanley »

Seelos Therapeutics Inc Class Equity shares owned by Morgan Stanley

Quarter-by-quarter ownership of Seelos Therapeutics Inc Class Equity shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Seelos Therapeutics Inc Class Equity

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Inc Class Equity held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Inc Class Equity by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $13k 22k 0.60

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Seelos Therapeutics Inc Class Equity

AdvisorShares Investments
Morgan Stanley
Geode Capital Management
BlackRock
Tower Research Capital
Jpmorgan Chase & Co
Bank of America Corporation
Group One Trading
Vermillion & White Wealth Management Group
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group
Westside Investment Management
National Bank Of Canada /fi/
Pnc Financial Services

View all funds holding Seelos Therapeutics Inc Class Equity